Log inSign up
AAOIFI No. 21 screening

Is LITS halal?

Lite Strategy, Inc.

Doubtful

No clear verdict is possible for Lite Strategy, Inc. — data is insufficient or the case is contested in fiqh. As a precaution it is NOT included in the halal list.

Checked: 14 October 2026

Exchange

NASDAQ

Price

1.15

Day

-3.77%

Market cap

$36.0M

Industry

Biotechnology

Sector

Healthcare

Manually identified reason

Automatic screening reads the industry label, not what's inside. This company's filings were checked by hand and a hidden prohibited activity was found:

Doubtful: crypto — Litecoin treasury (the 'Biotechnology' label is stale); scholarly disagreement + share/interest nature unclear

What the company does

Lite Strategy (formerly MEI Pharma) became a Litecoin crypto-treasury company in 2025 (advised by Charlie Lee); the old oncology program was halted. The Yahoo label ('Biotechnology') is outdated; its value tracks the Litecoin price.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    Doubtful: crypto — Litecoin treasury (the 'Biotechnology' label is stale); scholarly disagreement + share/interest nature unclear

  • Interest-bearing debt / market cap

    limit 30%

    0.0%

    Pass

  • Cash & investments / market cap

    limit 30%

    146.5%

    Fail

  • Non-compliant income / total revenue

    limit 5%

    —

    No data

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyLITS's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →